Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients

By                        

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2385-2398

Spandidos Publications

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3523-3532

Spandidos Publications

Access to resources Recommend Favorite

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients

By Hautala Laura   Greco Dario   Koistinen Riitta   Heikkinen Tuomas   Heikkilä Päivi   Aittomäki Kristiina   Blomqvist Carl   Koistinen Hannu   Nevanlinna Heli  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 85-95

Springer Publishing Company

Access to resources Recommend Favorite